Although continuous blood pressure (cBP) is a useful physiological indicator that can accurately and immediately notify changes in blood pressure, it is not utilized in daily life due to the limitations of the invasive measurement method and the porta...
Although continuous blood pressure (cBP) is a useful physiological indicator that can accurately and immediately notify changes in blood pressure, it is not utilized in daily life due to the limitations of the invasive measurement method and the portability of the measuring device. The purpose of this study is to propose a portable wearable continuous blood pressure measurement technology that can be used in daily life by convergence of the tonometry technique and the multi-wavelength photoplethysmogram (PPG) technique, and to validate its feasibility through clinical trials.
A multi-model wearable system was developed, and it was equipped with a multi-wavelength PPG for measuring depth-dependent blood volume and a multi-channel pressure sensor to measure changes in pressure over the radial artery. The blood pressure estimation algorithm was developed based on the bidirectional long short-term memory (Bi-LSTM) model. For validation feasibility of the developed system, a clinical trial was performed on a total of 26 patients, and signals were simultaneously acquired using the commercial invasive blood pressure measuring device (IBP) and the developed wearable device, and the resulting blood pressure values were compared. Among the 49 data repeatedly obtained from participants, 33 data with the highest quality were used for algorithm development.
In this study, two model types were trained and evaluated: a participant-specific Bi-LSTM model and a participant-independent (generalized) Bi-LSTM model. The acquired data was segmented into lengths of 2, 3, 4, and 5 seconds8. The participant-specific model demonstrated the best performance with the 2-second segmentation. The performance of the participant-specific Bi-LSTM model was evaluated by comparing data processing methods and validation strategies. The application of PCA preprocessing significantly enhanced the model's precision; under 10-fold cross-validation, the PCA-based model achieved an estimation error of (2.4 ± 0.8) mmHg for SBP, (1.1 ± 0.3) mmHg for DBP, and (1.8 ± 0.5) mmHg for cBP (coefficient of determination with 0.97, 0.98, and 0.99), which was a marked improvement over the non-PCA model's error of (2.9 ± 1.0) mmHg for SBP, (1.3 ± 0.3) mmHg for DBP, and (1.9 ± 0.5) mmHg for cBP. Furthermore, in chronological validation, the PCA-based model demonstrated robust performance with an error of (5.4 ± 4.0) mmHg for SBP, (2.2 ± 1.2) mmHg for DBP, and (3.6 ± 2.0) mmHg for cBP (coefficient of determination with 0.84, 0.91, and 0.94), consistently outperforming the non-PCA approach, which showed an error of (5.9 ± 3.8) mmHg for SBP, (2.2 ± 1.2) mmHg for DBP, and (3.7 ± 1.8) mmHg for DBP.
Based on the segmentation length findings, a participant-independent Bi-LSTM model applicable to all participants was developed using PCA-processed data from the entire cohort. The estimation error showed significant improvement, with (3.5 ± 3.6) mmHg for SBP and (1.6 ± 1.6) mmHg for DBP, as compared to IBP. The coefficients of determination were 0.92 and 0.95, respectively. The error for the continuous blood pressure waveform across all sample points was (2.6 ± 2.9) mmHg, with a coefficient of determination of 0.97. It was confirmed that the participant-independent Bi-LSTM model developed with PCA-processed data demonstrates a performance equivalent to Grade A of the British Hypertension Society (BHS) protocol, which is a certification standard for intermittent non-invasive blood pressure devices.
To ensure the usability of the system developed in this study in both clinical and daily life settings, further improvements are necessary. These include enhancing the reproducibility of device placement, increasing robustness against external noise such as motion artifacts, and conducting additional validation on a more diverse group of participants.